Ask Warren

IntoCell

287840 · KOSDAQ · ₩287840 · 인투셀

₩14,890▼ ₩640 (4.12%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩760M₩281M₩728M₩1.4B₩39M₩109M₩112M₩985M
Cost of sales———————₩0
Gross profit———————₩985M
Operating income−₩2.2B−₩3.5B−₩1.9B−₩1.3B−₩3.7B−₩3.4B−₩2.1B−₩2.3B
Net income₩1.9B−₩4B−₩9.5B₩2.7B−₩499M−₩3.4B−₩7.3B−₩1.7B
Net income to shareholders₩1.9B−₩4B−₩9.5B₩2.7B−₩499M−₩3.4B−₩7.3B−₩1.7B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩37B₩39B₩41B₩41B₩44B₩23B₩24B₩24B
Current assets₩25B₩28B₩31B₩31B₩35B₩12B₩13B₩14B
Cash and equivalents₩11B₩8.6B₩12B₩17B₩25B₩4.8B₩7B₩7.6B
Total liabilities₩17B₩17B₩17B₩17B₩19B₩19B₩16B₩15B
Current liabilities₩14B₩4.1B₩3.2B₩3.9B₩6B₩15B₩14B₩12B
Borrowings₩10B₩10B₩10B₩10B₩10B₩10B₩10B₩10B
Total equity₩20B₩21B₩25B₩24B₩25B₩3.9B₩7.5B₩9.6B
Shareholders' equity₩20B₩21B₩25B₩24B₩25B₩3.9B₩7.5B₩9.6B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩2.7B−₩3.1B−₩2B−₩2.5B−₩2.5B−₩1.7B−₩417M−₩4B
Capital spending₩113M₩3.9M₩27M₩70M₩2.9M₩44M₩28M₩4.3M
Free cash flow−₩2.8B−₩3.1B−₩2B−₩2.6B−₩2.5B−₩1.7B−₩445M−₩4.1B

Consolidated where available. Amounts in won.

Also known as: IntoCell / 인투셀 / 287840 / KRX:287840

Source: KRX statistical information